# Coherus Oncology, Inc.: Form DEF 14A, filed Apr 20, 2026

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: DEF 14A
- Filed: 2026-04-20
- Accepted by EDGAR: Apr 20, 2026, 08:26 ET
- Period: 2026-05-27
- Accession: 0001104659-26-045251
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000110465926045251/chrs-20260527xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000110465926045251/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000110465926045251/chrs-20260527xdef14a.htm

Filed Apr 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-045251. Last ingested by Listed: Nov 10, 2026, 03:58 ET. No prices; not investment advice.